ERBB2 and gastric cancer: Similarly, a Japanese nationwide post-marketing surveillance program found that among 130 patients with HER2-positive metastatic breast cancer or gastric cancer and adjudicated T-DXd-related ILD, the majority of cases (63.1%) had the OP pattern [62].